Ilaris
- Licence status
- Withdrawn: 01/01/2019
- Active substances
- Canakinumab
- Dosage Form
- Powder and solvent for solution for injection
- Licence number
- EU/1/09/564/003
- Licence holder
- Novartis Europharm Limited
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- L04AC Interleukin inhibitors, L04AC08 canakinumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription. (See Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 16/09/2011